Alterations in vaginal and urinary microbiota in menopause and associated pathologies: A narrative review

Abstract

Background: In the premenopausal stage, the vaginal microbiota is characterized by a high abundance of Lactobacillus, a key genus for preserving a healthy vaginal environment. However, the estrogen decline associated with menopause modifies this microbial community, leading to a reduction in Lactobacillus and promoting the proliferation of anaerobic bacteria, thereby increasing the risk of dysbiosis, as observed in bacterial vaginosis. Likewise, the urinary microbiota undergoes alterations that heighten the susceptibility of postmenopausal women to urinary tract infections. Hormonal changes also cause symptoms such as vaginal dryness, irritation, and dyspareunia, resulting from urogenital atrophy, which affects not only physical health but also emotional well-being and quality of life. Aim: The aim of the study was to describe the changes of the vaginal and urinary microbiota’s associated with estrogen deficiency in menopause, as well as their relationship with relevant clinical conditions, including pelvic floor diseases, genital infections, periodontal disease, and gynecological cancers. Relevance for patients: Understanding these microbial changes is crucial for optimizing clinical management and improving the overall health of women in this stage of life, as these alterations represent an emerging field of research with important diagnostic and therapeutic implications.

Keywords

Vaginal microbiota / Urinary microbiota / Menopause / Associated pathologies

Funding

None.

Conflict of interest

The author declares no conflict of interest.

References

[1] Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016; 91:42-50. doi: 10.1016/j.maturitas.2016.05.015

[2] Zhao F, Hu X, Ying C. Advances in research on the relationship between vaginal microbiota and adverse pregnancy outcomes and gynecological diseases. Microorganisms. 2023; 11(4):991. doi: 10.3390/microorganisms11040991

[3] Ovalle A, Oyarzún E. Microbiota y perfil inmunológico vaginal de la embarazada propensa a parto prematuro por infección bacteriana ascendente. Rev Chil Obstet Ginecol. 2024; 89(3):164-181. doi: 10.24875/rechog.23000039

[4] De Oliveira NS, De Lima ABF, De Brito JCR, Sarmento ACA, Gonçalves AKS, Eleutério J Jr. Postmenopausal vaginal microbiome and microbiota. Front Reprod Health. 2022; 3:780931. doi: 10.3389/frph.2021.780931

[5] Shen L, Zhang W, Yuan Y, Zhu W, Shang A. Vaginal microecological characteristics of women in different physiological and pathological period. Front Cell Infect Microbiol. 2022; 12:959793. doi: 10.3389/fcimb.2022.959793

[6] Vaughan MH, Mao J, Karstens LA, et al. The urinary microbiome in postmenopausal women with recurrent urinary tract infections. J Urol. 2021; 206(5):1222-1231. doi: 10.1097/JU.0000000000001940

[7] Naji A, Siskin D, Woodworth MH, Lee JR, Kraft CS, Mehta N. The role of the gut, urine, and vaginal microbiomes in the pathogenesis of urinary tract infection in women and consideration of microbiome therapeutics. Open Forum Infect Dis. 2024; 11(9):ofae471. doi: 10.1093/ofid/ofae471

[8] Barrea L, Verde L, Auriemma RS, et al. Probiotics and prebiotics: Any role in menopause-related diseases? Curr Nutr Rep. 2023; 12(1):83-97. doi: 10.1007/s13668-023-00462-3

[9] Kalia N, Singh J, Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: A critical review. Ann Clin Microbiol Antimicrob. 2020; 19(1):5. doi: 10.1186/s12941-020-0347-4

[10] Deka N, Hassan S, Seghal Kiran G, Selvin J. Insights into the role of vaginal microbiome in women’s health. J Basic Microbiol. 2021; 61(12):1071-1084. doi: 10.1002/jobm.202100421

[11] Ovalle A, Martínez MA. In: Guzmán E, editor. CAPÍTULO 30 “Infección Genital” Libro “Selección de Temas en Ginecoobstetricia Tomo II.” Chile: Editorial Publimpacto; 2007. p. 875-923.

[12] Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide-producing Lactobacilli and acquisition of vaginal infections. J Infect Dis. 1996; 174:1058-1063. doi: 10.1093/infdis/174.5.1058

[13] Vallor AC, Antonio MA, Hawes SE, Hillier SL. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: Role of hydrogen peroxide production. J Infect Dis. 2001; 184:1431-1436. doi: 10.1086/324445

[14] Hay P. Life in the littoral zone: Lactobacilli losing the plot. Sex Transm Infect. 2005; 81:100-102. doi: 10.1136/sti.2003.007161

[15] Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U SA. 2011; 108(Suppl 1):4680-1687. doi: 10.1073/pnas.1002611107

[16] Ratten LK, Plummer EL, Bradshaw CS, et al. The effect of exogenous sex steroids on the vaginal microbiota: A systematic review. Front Cell Infect Microbiol. 2021; 11:732423. doi: 10.3389/fcimb.2021.732423

[17] Gustafsson RJ, Ahrne S, Jeppsson B, et al. The Lactobacillus flora in vagina and rectum of fertile and postmenopausal healthy Swedish women. BMC Womens Health. 2011; 11(1):17. doi: 10.1186/1472-6874-11-17

[18] Zhang R, Daroczy K, Xiao B, Yu R, Liao Q. Qualitative and semiquantitative analysis of Lactobacillus species in the vaginas of healthy fertile and postmenopausal Chinese women. J Med Microbiol. 2012; 61(Pt 5):729-739. doi: 10.1099/jmm.0.038687-0

[19] Mirmonsef P, Hotton A.L, Gilbert D, et al. Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH. PLoS One. 2014; 9(7):e102467. doi: 10.1371/journal.pone.0102467

[20] Marconi C, El-Zein M, Ravel J, et al. Characterization of the vaginal microbiome in women of reproductive age from 5 regions in Brazil. Sex Transm Dis. 2020; 47:562-569. doi: 10.1097/OLQ.0000000000001204

[21] Brotman RM, Shardell MD, Gajer P, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2018; 25:1321-1330. doi: 10.1097/GME.0000000000001236

[22] Park MG, Cho S, Oh MM. Menopausal changes in the microbiome-a review focused on the genitourinary microbiome. Diagnostics (Basel). 2023; 13(6):1193. doi: 10.3390/diagnostics13061193

[23] Dodero VI, Morre´ SA, Behzadi P. Editorial: Gut microbiota and immunity in health and disease: Dysbiosis and eubiosis’s effects on the human body. Front Immunol. 2024; 15:1536258. doi: 10.3389/fimmu.2024.1536258

[24] Ervin SM, Li H, Lim L, et al. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens. J Biol Chem. 2019; 294:18586-18599. doi: 10.1074/jbc.RA119.010950

[25] Sze C, Pressler M, Lee JR, Chughtai B. The gut, vaginal, and urine microbiome in overactive bladder: A systematic review. Int Urogynecol J. 2022; 33(5):1157-1164. doi: 10.1007/s00192-022-05127-3

[26] Cocomazzi G, Del Pup L, Contu V, et al. Gynecological cancers and microbiota dynamics: Insights into pathogenesis and therapy. Int J Mol Sci. 2024; 25(4):2237. doi: 10.3390/ijms25042237

[27] Chase D, Goulder A, Zenhausern F, Monk B, Herbst- Kralovetz M. The vaginal and gastrointestinal microbiomes in gynecologic cancers: A review of applications in etiology, symptoms and treatment. Gynecol Oncol. 2015; 138:190-200. doi: 10.1016/j.ygyno.2015.04.036

[28] Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, et al. The urinary tract microbiome in health and disease. Eur Urol Focus. 2018; 4:128-138. doi: 10.1016/j.euf.2016.11.001

[29] Ammitzbøll N, Bau BPJ, Bundgaard-Nielsen C, et al. Pre- and postmenopausal women have different core urinary microbiota. Sci Rep. 2021; 11:2212. doi: 10.1038/s41598-021-81790-8

[30] Wolfe AJ, Brubaker L. Urobiome updates: Advances in urinary microbiome research. Nat Rev Urol. 2019; 16:73-74. doi: 10.1038/s41585-018-0127-5

[31] Lewis AL, Gilbert NM. Roles of the vagina and the vaginal microbiota in urinary tract infection: Evidence from clinical correlations and experimental models. GMS Infect Dis. 2020; 8:Doc02. doi: 10.3205/id000046.eCollection2020

[32] Stapleton AE. The vaginal microbiota and urinary tract infection. Microbiol Spectr. 2016; 4:1-9. doi: 10.1128/microbiolspec.UTI-0025-2016

[33] Magruder M, Sholi AN, Gong C, et al. Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019; 10:5521. doi: 10.1038/s41467-019-13467-w

[34] Jeney SES, Lane F, Oliver A, Whiteson K, Dutta S. Fecal microbiota transplantation for the treatment of refractory recurrent urinary tract infection. Obstet Gynecol. 2020; 136:771-773. doi: 10.1097/AOG.0000000000004052

[35] Neugent ML, Kumar A, Hulyalkar NV, et al. Recurrent urinary tract infection and estrogen shape the taxonomic ecology and function of the postmenopausal urogenital microbiome. Cell Rep Med. 2022; 3(10):100753. doi: 10.1016/j.xcrm.2022.100753

[36] Becker M, Sobel R. Current Infectious Disease Reports; 2023. p. 61-66. doi: 10.1007/s11908-023-00801-z

[37] Daniel AL, Auerbach S, Nazarenko D, Agbemenu K, Lorenz R. An integrative review of the relationship between intrauterine devices and bacterial vaginosis. Nurs Womens Health. 2023; 27(2):141-151. doi: 10.1016/j.nwh.2023.01.007

[38] Ijaz MU, Hayat MF, Ashraf A. Microbiome and Reproductive Health Human Microbiome: Techniques, Strategies, and Therapeutic Potential. Singapore: Springer Nature Singapore; 2024. p. 251-272.

[39] Ovalle A, Martínez MA, Casals A, Yuhaniak R, Giglio MS. Estudio clínico y microbiológico de la enfermedad inflamatoria pélvica aguda [Clinical and microbiological study of acute pelvic inflammatory disease]. Rev Chil Obstet Ginecol. 1993; 58(2):103-112. Spanish. Erratum in: Rev Chil Obstet Ginecol. 1993; 58(4):330.

[40] Wang Z, Zhang L, Liu X, Xu L. The role of reproductive tract microbiota in gynecological health and diseases. J Reprod Immunol. 2025; 167:104418. doi: 10.1016/j.jri.2024.104418

[41] Turpin R, Tuddenham S, He X, Klebanoff MA, Ghanem KG, Brotman RM. Bacterial vaginosis and behavioral factors associated with incident pelvic inflammatory disease in the longitudinal study of vaginal flora. J Infect Dis. 2021; 224(12Suppl 2):S137-S144. doi: 10.1093/infdis/jiab103

[42] Ovalle A, Casanova A, Kakarieka E, De Jourdan F, Salgado K. Epidemiology, clinical outcomes, and treatment costs for tubo-ovarian abscesses in a public hospital in Santiago. Rev Chil Obstet Ginecol. 2008; 73(6):374-380. doi: 10.4067/S0717-75262008000600004

[43] Kagan R, Kellogg-Spadt S, Parish SJ. Practical treatment considerations in the management of genitourinary syndrome of menopause. Drugs Aging. 2019; 36(10):897-908. doi: 10.1007/s40266-019-00700-w

[44] Shardell M, Gravitt PE, Burke AE, Ravel J, Brotman RM. Association of vaginal microbiota with signs and symptoms of the genitourinary syndrome of menopause across reproductive stages. J Gerontol A Biol Sci Med Sci. 2021; 76(9):1542-1550. doi: 10.1093/gerona/glab120

[45] Zeng Q, Shu H, Pan H, et al. Associations of vaginal microbiota with the onset, severity, and type of symptoms of genitourinary syndrome of menopause in women. Front Cell Infect Microbiol. 2024; 14:1402389. doi: 10.3389/fcimb.2024.1402389

[46] Cuccu I, Golia D’Augè T, Firulli I, et al. Update on genitourinary syndrome of menopause: A scoping review of a tailored treatment-based approach. Life (Basel). 2024; 14(11):1504. doi: 10.3390/life14111504

[47] Muiños Fernández N, Martínez Salamanca JI, Pardo González De Quevedo JI, et al. Efficacy and safety of an ultra-low-dose 0.005 % estriol vaginal gel in the prevention of urinary tract infections in postmenopausal women with genitourinary syndrome of menopause: A randomized double-blind placebo-controlled trial. Maturitas. 2024; 190:108128. doi: 10.1016/j.maturitas.2024.108128

[48] Mei Z, Li D. The role of probiotics in vaginal health. Front Cell Infect Microbiol. 2022; 12:963868. doi: 10.3389/fcimb.2022.963868

[49] Balaouras G, Kostoulas P, Mikos T, Balaouras D, Chitzios D. The study of microbiome of the female genital area in relation to pelvic floor dysfunction: A systematic review. Int Urogynecol J. 2024; 35(7):1347-1362. doi: 10.1007/s00192-024-05821-4

[50] Li K, Chen C, Zeng J, et al. Interplay between bladder microbiota and overactive bladder symptom severity: A cross-sectional study. BMC Urol. 2022; 22(1):39. doi: 10.1186/s12894-022-00990-0

[51] Carnes MU, Siddiqui NY, Karstens L, et al. Urinary microbiome community types associated with urinary incontinence severity in women. Am J Obstet Gynecol. 2024; 230(3):344.e1-344.e20. doi: 10.1016/j.ajog.2023.10.036

[52] Antunes-Lopes T, Vale L, Coelho AM, et al. The role of urinary microbiota in lower urinary tract dysfunction: A systematic review. Eur Urol Focus. 2020; 6(2):361-369. doi: 10.1016/j.euf.2018.09.011

[53] Hilt EE, McKinley K, Pearce MM, et al. Urine is not sterile: Use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014; 52(3):871-876. doi: 10.1128/JCM.02876-13

[54] Pearce M, Zilliox M, Rosenfeld AB, et al. The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol. 2015; 213:347.e1-11. doi: 10.1016/j.ajog.2015.07.009

[55] Yu Y, Ma M, Zhou Q. The relationship between vaginal microenvironment and pelvic dysfunctional diseases in Chinese women: A systematic review and meta-analysis. Int Urogynecol J. 2023; 34(12):2849-2858. doi: 10.1007/s00192-023-05635-w

[56] Łaniewski P, Ilhan ZE, Herbst-Kralovetz MM. The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. 2020; 17(4):232-250. doi: 10.1038/s41585-020-0286-z

[57] Khan AA, Sirsat AT, Singh H, Cash P. Microbiota and cancer: Current understanding and mechanistic implications. Clin Transl Oncol. 2022; 24:193-202. doi: 10.1007/s12094-021-02690-x

[58] Francescone R, Hou V, Grivennikov SI. Microbiome, inflammation, and cancer. Cancer J. 2014; 20:181-189. doi: 10.1097/PPO.0000000000000048

[59] Zhao LY, Mei JX, Yu G, et al. Role of the gut microbiota in anticancer therapy: From molecular mechanisms to clinical applications. Signal Transduct Target Ther. 2023; 13;8(1): 201. doi: 10.1038/s41392-023-01406-7

[60] Loo TM, Kamachi F, Watanabe Y, et al. Gut microbiota promotes obesity-associated liver cancer through PGE₂- mediated suppression of antitumor immunity. Cancer Discov. 2017; 7:522-538. doi: 10.1158/2159-8290.CD-16-0932

[61] Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345:784-789. doi: 10.1056/NEJMoa001999

[62] Wang N, Fang JY. Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer. Trends Microbiol. 2023; 31:159-172. doi: 10.1016/j.tim.2022.08.010

[63] Zadora PK, Chumduri C, Imami K, et al. Integrated phosphoproteome and transcriptome analysis reveals chlamydia-induced epithelial-to-mesenchymal transition in host cells. Cell Rep. 2019; 26:1286-1302.e8. doi: 10.1016/j.celrep.2019.01.006

[64] Takada K, Melnikov VG, Kobayashi R, Komine-Aizawa S, Tsuji NM, Hayakawa S. Female reproductive tract-organ axes. Front Immunol. 2023; 14:1110001. doi: 10.3389/fimmu.2023.1110001

[65] Mirabello L, Clarke MA, Nelson CW, et al. The intersection of HPV epidemiology, genomics and mechanistic studies of HPV-mediated carcinogenesis. Viruses. 2018; 10(2):80. doi: 10.3390/v10020080

[66] Siegel RL, Fedewa SA, Miller KD, et al. Cancer statistics for hispanics/latinos, 2015. CA Cancer J Clin. 2015; 65:457-480. doi: 10.3322/caac.21314

[67] Mirkovic J, Howitt BE, Roncarati P, et al. Carcinogenic HPV infection in the cervical squamo-columnar junction. J Pathol. 2015; 236:265-271. doi: 10.1002/path.4533

[68] Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat. 2005; 37:319-324. doi: 10.4143/crt.2005.37.6.319

[69] Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: What do we know and where are we going next? Microbiome. 2016; 4:58. doi: 10.1186/s40168-016-0203-0

[70] Prozialeck WC, Fay MJ, Lamar PC, Pearson CA, Sigar I, Ramsey KH. Chlamydia trachomatis disrupts N-cadherin-dependent cell-cell junctions and sequesters beta-catenin in human cervical epithelial cells. Infect Immun. 2002; 70:2605-2613. doi: 10.1128/IAI.70.5.2605-2613.2002

[71] Oh HY, Kim BS, Seo SS, et al. The association of uterine cervical microbiota with an increased risk for cervical intraepithelial neoplasia in Korea. Clin Microbiol Infect. 2015; 21:674.e1-9. doi: 10.1016/j.cmi.2015.02.026

[72] Gao W, Weng J, Gao Y, Chen X. Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: A cross-sectional study. BMC Infect Dis. 2013; 13:271. doi: 10.1186/1471-2334-13-271

[73] Lee JE, Lee S, Lee H, et al. Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort. PLoS One. 2013; 8(5):e63514. doi: 10.1371/journal.pone.0063514

[74] Di Paola M, Sani C, Clemente AM, et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk human papillomavirus infection. Sci Rep. 2017; 7:10200. doi: 10.1038/s41598-017-09842-6

[75] Doll KM, Snyder CR, Ford CL. Endometrial cancer disparities: A race-conscious critique of the literature. Am J Obstet Gynecol. 2018; 218:474-482.e2. doi: 10.1016/j.ajog.2017.09.016

[76] Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology. 2009; 136:1476-1483. doi: 10.1053/j.gastro.2009.03.030

[77] Si J, You HJ, Yu J, Sung J, Ko G. Prevotella as a hub for vaginal microbiota under the influence of host genetics and their association with obesity. Cell Host Microbe. 2017; 21:97-105. doi: 10.1016/j.chom.2016.11.010

[78] Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004; 4:579-591. doi: 10.1038/nrc1408

[79] Han M, Wang N, Han W, Ban M, Sun T, Xu J. Gut microbes in gynecologic cancers: Causes or biomarkers and therapeutic potential. Front Oncol. 2022; 12:902695. doi: 10.3389/fonc.2022.902695

[80] Baker JM, Chase DM, Herbst-Kralovetz MM. Uterine microbiota: Residents, tourists, or invaders? Front Immunol. 2018; 9:208. doi: 10.3389/fimmu.2018.00208

[81] Canha-Gouveia A, Pérez-Prieto I, Rodríguez CM, et al. The female upper reproductive tract harbors endogenous microbial profiles. Front Endocrinol (Lausanne). 2023; 14:1096050. doi: 10.3389/fendo.2023.1096050

[82] Chen C, Song X, Wei W, et al. The microbiota continuum along the female reproductive tract and its relation to uterine-related diseases. Nat Commun. 2017; 8:875. doi: 10.1038/s41467-017-00901-0

[83] Walther-António MR, Chen J, Multinu F, et al. Potential contribution of the uterine microbiome in the development of endometrial cancer. Genome Med. 2016; 8:122. doi: 10.1186/s13073-016-0368-y

[84] Aquino CI, Nicosia A, Ligori A, Volpicelli AI, Surico D. Microbiota status and endometrial cancer: A narrative review about possible correlations in affected versus healthy patients. Science. 2024; 6:75. doi: 10.3390/sci6040075

[85] Hirata T, Osuga Y, Hamasaki K, et al. Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology. 2008; 149:1260-1267. doi: 10.1210/en.2007-0749

[86] Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe. 2011; 10:324-335. doi: 10.1016/j.chom.2011.10.003

[87] Wang L, Yang J, Su H, Shi L, Chen B, Zhang S. Endometrial microbiota from Endometrial cancer and paired pericancer tissues in postmenopausal women: Differences and clinical relevance. Menopause. 2022; 29:1168-1175. doi: 10.1097/GME.0000000000002053

[88] Javadi K1 Ferdosi-Shahandashti E, Rajabnia M, Khaledi M. Vaginal microbiota and gynecological cancers: A complex and evolving relationship. Infect Agent Cancer. 2024; 19(1):27. doi: 10.1186/s13027-024-00590-7

[89] Sipos A, Ujlaki G, Mikó E, et al. The role of the microbiome in ovarian cancer: Mechanistic insights into oncobiosis and to bacterial metabolite signaling. Mol Med. 2021; 27(1):33. doi: 10.1186/s10020-021-00295-2

[90] Banerjee S, Tian T, Wei Z, et al. The ovarian cancer oncobiome. Oncotarget. 2017; 8:36225-36245. doi: 10.18632/oncotarget.16717

[91] Zhou B, Sun C, Huang J, et al. The biodiversity composition of microbiome in ovarian carcinoma patients. Sci Rep. 2019; 9(1):1691. doi: 10.1038/s41598-018-38031-2

[92] Huang Q, Wei X, Li W, et al. Endogenous Propionibacterium acnes promotes ovarian cancer progression via regulating hedgehog signalling pathway. Cancers (Basel). 2022; 14(21):5178. doi: 10.3390/cancers14215178

[93] Xu J, Peng JJ, Yang W, Fu K, Zhang Y. Vaginal microbiomes and ovarian cancer: A review. Am J Cancer Res. 2020; 10:743-756.

[94] Nené NR, Reisel D, Leimbach A, et al. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: A case-control study. Lancet Oncol. 2019; 20(8):1171-1182. doi: 10.1016/S1470-2045(19)30340-7

[95] Trabert B, Waterboer T, Idahl A, et al. Antibodies against Chlamydia trachomatis and ovarian cancer risk in two independent populations. J Natl Cancer Inst. 2019; 111:129-136. doi: 10.1093/jnci/djy084

[96] Li C, Feng Y, Yang C, et al. Association between vaginal microbiota and the progression of ovarian cancer. J Med Virol. 2023; 95(7):e28898. doi: 10.1002/jmv.28898

[97] Agrawal R, Ahmed H, Soorgani N, Naik L, Reddy S, Medabalmi M. Assessment of periodontal status in pre- and postmenopausal women with chronic periodontitis: A crosssectional study. J Pharm Bioall Sci. 2021; 13:S997-S999. doi: 10.4103/jpbs.jpbs_145_21

[98] Slots J, Ting M. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: Occurrence and treatment. Periodontol 2000. 1999; 20:82121. doi: 10.1111/j.1600-0757.1999.tb00155.x

[99] Ovalle A, Gamonal J, Martínez MA, et al. Relación entre enfermedad periodontal, infección bacteriana ascendente y patología placentaria con parto prematuro [Relationship between periodontal diseases and ascending bacterial infection with preterm delivery]. Rev Med Chil. 2009; 137(4):504-514.

[100] León R, Silva N, Ovalle A, et al. Detection of Porphyromonas gingivalis in the amniotic fluid in pregnant women with a diagnosis of threatened premature labor. J Periodontol. 2007; 78(7):1249-1255. doi: 10.1902/jop.2007.060368

[101] Singh M, Singhal R, Negi R, et al. Periodontal status in pre-and post-menopausal women: A review. Asian Pac J Health Sci. 2018; 5(2):136-142. doi: 10.21276/apjhs.2018.5.2.26

[102] Di Naro E, Loverro M, Converti I, Loverro MT, Ferrara E, Rapone B. The effect of menopause hypoestrogenism on osteogenic differentiation of periodontal ligament cells (PDLC) and stem cells (PDLCs): A systematic review. Healthcare (Basel). 2021; 9(5):572. doi: 10.3390/healthcare9050572

[103] Amabebe E, Anumba DO. Female gut and genital tract microbiota-induced crosstalk and differential effects of short-chain fatty acids on immune sequelae. Front Immunol. 2020; 11:2184. doi: 10.3389/fimmu.2020.02184

[104] Balle C, Esra R, Havyarimana E, et al. Relationship between the oral and vaginal microbiota of South African adolescents with high prevalence of bacterial vaginosis. Microorganisms. 2020; 8(7):1004. doi: 10.3390/microorganisms8071004